Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis

INTRODUCTION: The summary of product characteristics of vaccines administered intramuscularly, including the vaccine for coronavirus SARS-CoV-2 (COVID-19) and Influenza, warned for risks of bleeding in patients treated with oral anticoagulants. We aimed to estimate the incidence of major bleeding ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldeira, Daniel, Rodrigues, Bárbara Sucena, Alves, Mariana, Pinto, Fausto J., Ferreira, Joaquim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848629/
https://www.ncbi.nlm.nih.gov/pubmed/35172841
http://dx.doi.org/10.1186/s12959-022-00367-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848629/
https://www.ncbi.nlm.nih.gov/pubmed/35172841
http://dx.doi.org/10.1186/s12959-022-00367-1

Ejemplares similares